Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): a phase II trial (Q33406049)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): a phase II trial
scientific article

    Statements

    Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): a phase II trial (English)
    Radj Gervais
    Gilles Robinet
    Christelle Clément-Duchêne
    Fabrice Denis
    Claude El Kouri
    Philippe Martin
    Nadia Chouaki
    Nawel Bourayou
    Jean-François Morère
    21 February 2013

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit